NCT02495402 is a NA clinical trial of Motivational Interviewing in Substance Use, sponsored by RTI International.

Who is sponsoring NCT02495402?

NCT02495402 is sponsored by RTI International.

What drugs are being tested in NCT02495402?

Interventions in NCT02495402: Motivational Interviewing.

What condition does NCT02495402 study?

NCT02495402 studies Substance Use.

Is NCT02495402 still recruiting?

NCT02495402 is currently completed. Last updated 9 May 2018.

Last reviewed 2018-05-09 · How we verify

NCT02495402

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment

Completed NA Last updated 9 May 2018

What this trial tests

NA trial testing Motivational Interviewing in Substance Use in 827 participants. Completed in 25 March 2018.

Timeline

8 July 2015

Primary endpoint
28 December 2017

25 March 2018

Quick facts

Lead sponsor	RTI International
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	827
Start date	8 July 2015
Primary completion	28 December 2017
Estimated completion	25 March 2018
Sites	39 locations across United States

Drugs / interventions tested

Motivational Interviewing

Conditions studied

Substance Use — all drugs for Substance Use →

Sponsor

RTI International — full company profile →

Who can join

Adults 18 to 99, any sex, with Substance Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To test the effectiveness of a single 20-30 minute motivational interviewing-based brief intervention for substance use within HIV/AIDS settings.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based AIDS service organizations: study protocol for a multisite randomized controlled trial.
Garner BR, Gotham HJ, Tueller SJ, Ball EL, et al · · 2017 · cited 19× · PMID 29149914 · DOI 10.1186/s13722-017-0095-8
The implementation & sustainment facilitation (ISF) strategy: Cost and cost-effectiveness results from a 39-site cluster randomized trial integrating substance use services in community-based HIV service organizations.
Hinde JM, Garner BR, Watson CJ, Ramanan R, et al · · 2022 · cited 12× · PMID 37091108 · DOI 10.1177/26334895221089266
A peek behind the curtain: exploring coaching styles within the implementation and sustainment facilitation (ISF) strategy in the substance abuse treatment to HIV care study.
Ford JH, Gilson AM, Maurer MA, Hoffman KA, et al · · 2021 · cited 2× · PMID 34930497 · DOI 10.1186/s43058-021-00246-2
The Implementation & Sustainment Facilitation Strategy improved implementation effectiveness and intervention effectiveness: Results from a cluster-randomized type 2 hybrid trial
Garner B, Gotham H, Chaple M, Martino S, et al · · 2020 · DOI 10.21203/rs.3.rs-17375/v1

Verify or expand the search:

Other trials of Motivational Interviewing

Trials testing the same drug.

NCT07218471 — Cannabis Reduction and Functional Outcomes · NA · recruiting
NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
NCT07364773 — Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing · NA · recruiting
NCT07169955 — The Effect of Motivational Interviewing on Patients With Lumbar Discectomy · NA · completed
NCT06852664 — Improving Activity in Individuals With Cerebral Palsy · NA · recruiting

Other recruiting trials for Substance Use

Currently open trials in the same condition.

NCT07075081 — Gii'Igoshimong: Sitting With Your First Family · Phase 2 · recruiting
NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
NCT07509853 — Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engag · NA · recruiting
NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
NCT07512869 — Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Impl · recruiting

Other RTI International trials

Trials by the same sponsor.

NCT07226401 — Virtual Village for Young Parents · NA · recruiting
NCT06778278 — Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans · NA · recruiting
NCT06927661 — ENSAND 2.0 Evaluation in Nigeria · NA · recruiting
NCT06927674 — DELIVER Evaluation in Nigeria · NA · recruiting
NCT05971888 — Better Dairy for All Evaluation in Ethiopia · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02495402 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RTI International
Last refreshed: 9 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02495402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing